DCGO: Multiplikator rega marang pendapatan DocGo Inc
DocGo Inc. efficiency relies on mobile teams and government contracts, yet labor shortages and rising resource costs in the US are weighing on profitability. After reviewing the price-to-sales ratio on GURU.Markets, we see that 0.10 describes the current status of the metric. DocGo Inc. maintains its position through tech-driven logistics management and long-term government agreements, successfully resisting price dumping.
Rincian metrik lan analitis perusahaan DocGo Inc (DCGO)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Koefisien Total Utang marang Modal DocGo Inc.|DCGO - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal DocGo, Inc|DCGO - Gunggung utang perusahaan|Utang marang nilai buku DocGo Inc|DCGO - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka cendhak DocGo|Rasio likuiditas darurat docgo.com
- data bathi lan kelipatan valuasi:
DCGO - Bathi resik|Bathi mangsa ngarep DocGo Inc.|DCGO - Pangali P/E|Pangali forward rega marang bathi DocGo, Inc.|DCGO - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan DocGo Inc|DCGO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan DocGo|DCGO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan docgo.com|DCGO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep DocGo Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Analisis umum perusahaan:DCGO (docgo.com)
An investment audit of DocGo Inc. (DCGO) requires an analysis of market capitalization relative to annual sales volume, which determines the valuation of a single dollar of revenue within the pricing structure. This price-to-sales ratio is critical during a business model pivot toward the B2B segment, as it reflects market confidence in the company's ability to replace government contracts with private corporate orders.
Karo sapa DocGo Inc. saingan
Kapitalisasi marang pendapatan hcahealthcare.com HCA|Multiplikator P/S THC (Tenet Healthcare Corporation)|Multiplikator rega marang pendapatan Fresenius Medical Care AG|SOLV - Rasio rega marang pendapatan|Rega marang dodolan Encompass|UHS (uhsinc.com) - Kapitalisasi marang pendapatan|davita.com - Rasio kapitalisasi pasar marang pendapatan|RDNT (RadNet) - Multiplikator P/S|Option Care (OPCH) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Surgery Partners Corp (SGRY)|Premier Health - Rasio kapitalisasi marang pendapatan|Multiplikator P/S EYE (National Vision Holdings)|PGNY - Kapitalisasi marang pendapatan|ARDT: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Select Medical Corporation SEM|ASTH: Multiplikator P/S|Rasio kapitalisasi marang pendapatan MD|USPH (US Physical Therapy) - Multiplikator P/S|Kapitalisasi marang pendapatan pennantgroup.com (PNTG)|Multiplikator P/S ORGO|Nutex Health Inc (NUTX) - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Auna Health AUNA|SBC Medical Group Holdings (SBC) - Rega marang dodolan|EOLS: Kapitalisasi marang pendapatan|chs.net - Kapitalisasi marang volume dodolan|beautyhealth.com (SKIN) - Rasio rega marang pendapatan|MediWound - Rasio kapitalisasi pasar marang pendapatan|BTMD (Biote Corp) - Multiplikator P/S|Rega marang dodolan The Joint JYNT|Multiplikator P/S PIII|Multiplikator P/S gaintherapeutics.com (GANX)|EUDA Health Holdings Limited - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan BMGL (Basel Medical)|CLGN - Rasio rega marang pendapatan|Cuprina Holdings Limited (CUPR) - Kapitalisasi marang pendapatan|CCM: Multiplikator P/S|Rega marang dodolan ashs.com (AMS)|Rasio rega marang pendapatan MEDIROM Healthcare Group|Rasio kapitalisasi marang pendapatan ALBT (Avalon GloboCare Corporation)|Kapitalisasi marang pendapatan DHAI (DIH Holding US Inc.)|Kapitalisasi marang volume dodolan XAGE|Multiplikator P/S NIVF (NewGenIvf Group Limited)|ATIP: Rasio kapitalisasi marang pendapatan|CMAX - Rasio rega marang pendapatan|Rega marang dodolan Kindly MD Inc|MODV: Multiplikator P/S|Kapitalisasi marang pendapatan Novo Integrated Sciences Corp|SSY (SunLink Health Systems Inc.) - Multiplikator P/S|BACK - Multiplikator rega marang pendapatan
